Skip to main content

Celldex Therapeutics, Inc 10-Q for FY2026 Q1

Celldex Therapeutics, Inc. (CLDX)

10-Q 2026-05-07 For: 2026-03-31
View Original
Added on May 07, 2026

About this 10-Q

Celldex Therapeutics, Inc filed this 10-Q on May 7, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$15K
down 97.8% from $695K a year earlier
Net loss
$78.69M
compared with a net loss of $53.8M a year earlier
Diluted EPS
-$1.18
compared with -$0.81 a year earlier